To answer these questions, FiercePharma and Catalent recently conducted a survey to understand the factors affecting innovators’ decision to choose a particular dosage form. In this webinar, industry experts will present the survey results and share insights on how advanced dosage forms can address the specific attributes of a molecule, and patients’ needs.
Register for the webinar to learn about the tools and technologies for creating dosage forms such as orally disintegrating tablets (ODTs), multi-particulates, and modified release formulations.
Key learnings include:
- How to choose the dosage form and technologies to optimize the molecule to meet patients’ needs
- The value of advanced dosage forms to both new and existing molecules
- Understanding the tools and techniques for creating advanced dosage forms